Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 1, Pages e16333
Publisher
Public Library of Science (PLoS)
Online
2011-01-27
DOI
10.1371/journal.pone.0016333
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans
- (2014) Kenneth Von Eschen et al. Human vaccines & immunotherapeutics
- Elucidation of the MD-2/TLR4 Interface Required for Signaling by Lipid IVa
- (2014) C. Walsh et al. JOURNAL OF IMMUNOLOGY
- Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation
- (2014) H. Shen et al. JOURNAL OF IMMUNOLOGY
- Differential Activation of Human TLR4 by Escherichia coli and Shigella flexneri 2a Lipopolysaccharide: Combined Effects of Lipid A Acylation State and TLR4 Polymorphisms on Signaling
- (2014) P. Rallabhandi et al. JOURNAL OF IMMUNOLOGY
- Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis
- (2014) S. Bertholet et al. JOURNAL OF IMMUNOLOGY
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis
- (2010) Evaldo Nascimento et al. VACCINE
- Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
- (2009) Ryan C. Anderson et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Vaccination with the ML0276 Antigen Reduces Local Inflammation but Not Bacterial Burden during Experimental Mycobacterium leprae Infection
- (2009) V. S. Raman et al. INFECTION AND IMMUNITY
- Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A
- (2009) Caglar Cekic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
- (2009) Mark E. Polhemus et al. PLoS One
- Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
- (2009) Iván D. Vélez et al. VACCINE
- Optimized subunit vaccine protects against experimental leishmaniasis
- (2009) Sylvie Bertholet et al. VACCINE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
- (2009) Susan L. Baldwin et al. VACCINE
- Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions
- (2008) Christopher B. Fox et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started